Back to 
State Street Corp.
State Street Corp.
DBTX
Showing 0 of 11 quarters
Position history for State Street Corp.'s holdings in Decibel Therapeutics Inc
No. State Street exited its DBTX (Decibel Therapeutics) position in Q3 2023. Its Q2 2023 13F listed 40,960 shares worth $157,696. State Street already held DBTX in its Q1 2021 13F, the earliest on record, and held it in 9 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of DBTX: Citadel Advisors LLC, Alphabet Inc.